Will there be a generic version of Tymlos?
As of early 2024, there is no generic version of Tymlos (abaloparatide) available in the United States. The drug is currently protected by patents. However, patent expiry dates can shift due to various legal challenges and extensions. According to DrugPatentWatch.com, the earliest anticipated patent expiry for Tymlos is in 2034 [1].
When might a generic version of Tymlos become available?
The earliest projected date for a generic version of Tymlos to become available is 2034, based on patent information [1]. This timeline could change if patent challenges or other legal proceedings occur.
What is Tymlos used for?
Tymlos is a prescription medication used to treat osteoporosis in postmenopausal women who are at high risk for fracture [2]. It is a bone-forming drug that works by increasing bone mass [2].
How does Tymlos work?
Tymlos is a synthetic peptide analog of human parathyroid hormone-related peptide (PTHrP) [3]. It binds to the PTH type 1 receptor and stimulates osteoblasts, which are cells that build bone [3]. This leads to an increase in bone mineral density and an improvement in bone structure, ultimately reducing the risk of fractures.
Are there other treatments for osteoporosis?
Yes, other treatments for osteoporosis include bisphosphonates, denosumab (Prolia, Xgeva), romosozumab (Evenity), and estrogen therapy. These medications work through different mechanisms to either slow bone loss or promote bone formation.
What are the potential risks or side effects of Tymlos?
Common side effects of Tymlos include injection site reactions, nausea, and hypercalcemia (high calcium levels in the blood) [2]. A boxed warning notes that Tymlos may cause osteosarcoma (a type of bone cancer) based on studies in rats, and it should not be used in patients with Paget's disease of bone or unexplained elevations of alkaline phosphatase, skeletal metastases, or bone sarcomas [2]. Patients should discuss any concerns with their healthcare provider.
Where can I find more information on Tymlos patents?
Information regarding Tymlos patents and potential generic entry dates can be found on DrugPatentWatch.com [1].
---
Sources
1. https://www.drugpatentwatch.com/
2. https://www.tymlos.com/
3. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209204s000lbl.pdf